{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T10:11:39Z","timestamp":1776766299640,"version":"3.51.2"},"reference-count":66,"publisher":"Georg Thieme Verlag KG","issue":"09","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pneumologie"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>\n   Die interstitiellen Lungenerkrankungen (ILD) stellen eine Reihe heterogener pulmonaler Ver\u00e4nderungen dar, die durch Entz\u00fcndung und Fibrose des Lungeninterstitiums gekennzeichnet sind. Sie stellen eine Krankheitsentit\u00e4t dar, die durch eine hohe Symptomlast und eine begrenzte Therapiem\u00f6glichkeit charakterisiert ist. Die Aspekte der palliativen Versorgungsstrategien bei interstitiellen Lungenerkrankungen gewinnen eine zunehmende Bedeutung. Hierzu wird die gegenw\u00e4rtige Datenlage dargestellt und bewertet.\n    <\/jats:p>","DOI":"10.1055\/a-2624-3671","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T19:27:06Z","timestamp":1749756426000},"page":"643-652","source":"Crossref","is-referenced-by-count":2,"title":["Palliative Aspekte bei interstitiellen Lungenerkrankungen (ILD)"],"prefix":"10.1055","volume":"79","author":[{"given":"Michael","family":"Westhoff","sequence":"additional","affiliation":[{"name":"Pneumology, Lungenklinik Hemer, Hemer, Deutschland"},{"name":"Private University Witten\/Herdecke, Witten, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Delis","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Pneumologie, Palliativmedizin und Geriatrie, Helios Klinikum Emil von Behring GmbH, Berlin, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"00058","DOI":"10.1183\/23120541.00058-2022","article-title":"Interstitial lung disease incidence and mortality in the UK and the European Union: an observational study, 2001\u20132017","volume":"8","author":"JD Salciccioli","year":"2022","journal-title":"ERJ Open Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"G Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pupt.2017.02.005","article-title":"The earlier, the better: Impact of early diagnosis on clinical outcome in idiopathic pulmonary fibrosis","volume":"44","author":"M Aiello","year":"2017","journal-title":"Pulm Pharmacol Ther"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/resp.14154","article-title":"Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden","volume":"27","author":"L Lancaster","year":"2022","journal-title":"Respirology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.029783","article-title":"A scoping review of the unmet needs of patients diagnosed with idiopathic pulmonary fibrosis (IPF)","volume":"19","author":"C Bramhill","year":"2024","journal-title":"PLoS ONE"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"00065","DOI":"10.1183\/23120541.00065-2016","article-title":"What patients with pulmonary fibrosis and their partners think: a live, educative survey in the Netherlands and Germany","volume":"3","author":"MJ van Manen","year":"2017","journal-title":"ERJ Open Res"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/s13054-015-1124-1","article-title":"Intensive care at the end of life in patients dying due to non-cancer chronic diseases versus cancer: a nationwide study in Denmark","volume":"19","author":"T Lyngaa","year":"2015","journal-title":"Crit Care"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/thoraxjnl-2021-218440","article-title":"Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis","volume":"78","author":"A Chandel","year":"2023","journal-title":"Thorax"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1136\/thoraxjnl-2015-207439","article-title":"End-of-life care in oxygen-dependent ILD compared with lung cancer: a national population-based study","volume":"71","author":"Z Ahmadi","year":"2016","journal-title":"Thorax"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00127-2023","article-title":"Mortality surrogates in combined pulmonary fibrosis and emphysema","volume":"63","author":"A Zhao","year":"2024","journal-title":"Eur Respir J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1087485","article-title":"Clinical implications of interstitial pneumonia with autoimmune features diagnostic criteria in idiopathic pulmonary fibrosis: A case control study","volume":"10","author":"S Tomassetti","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/crj.13304","article-title":"Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis","volume":"15","author":"K Miyashita","year":"2021","journal-title":"Clin Respir J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.chest.2022.01.007","article-title":"Acute Respiratory Deterioration in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Single-Center Study","volume":"162","author":"BS Kwon","year":"2022","journal-title":"Chest"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report","volume":"194","author":"HR Collard","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.resmer.2022.100948","article-title":"French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis \u2013 2021 update. Full-length version","volume":"83","author":"V Cottin","year":"2023","journal-title":"Respir Med Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s12931-024-03048-x","article-title":"Acute exacerbation of progressive pulmonary fibrosis: incidence and outcomes","volume":"25","author":"MJ Kim","year":"2024","journal-title":"Respir Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0050-2017","article-title":"Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis","volume":"26","author":"Y Kondoh","year":"2017","journal-title":"Eur Respir Rev"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1055\/a-2079-4210","article-title":"Palliativmedizinische Aspekte in der klinischen Akut- und Notfallmedizin sowie Intensivmedizin, Konsensuspapier der DGIIN, DGK, DGP, DGHO, DGfN, DGNI, DGG, DGAI, DGINA und DG Palliativmedizin","volume":"77","author":"G Michels","year":"2023","journal-title":"Pneumologie"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.029783","article-title":"A scoping review of the unmet needs of patients diagnosed with idiopathic pulmonary fibrosis (IPF)","volume":"19","author":"C Bramhill","year":"2024","journal-title":"PLoS ONE"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1055\/s-0042-110711","article-title":"Behandlung im Voraus planen (Advance Care Planning): ein neues Konzept zur Realisierung wirksamer Patientenverf\u00fcgungen","volume":"17","author":"J In der Schmitten","year":"2016","journal-title":"Z Palliativmed"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/bmjspcare-2018-001575","article-title":"Barriers to specialist palliative care in interstitial lung disease: a systematic review","volume":"9","author":"JW Kim","year":"2019","journal-title":"BMJ Support Palliat Care"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04307-2020","article-title":"Referral criteria to palliative care for patients with respiratory disease: a systematic review","volume":"58","author":"J Philip","year":"2021","journal-title":"Eur Respir J"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e2649","DOI":"10.1136\/bmjspcare-2021-003249","article-title":"Fibrotic interstitial lung disease \u2013 palliative care needs: a World-Caf\u00e9 qualitative study","volume":"14","author":"N Cassidy","year":"2024","journal-title":"BMJ Support Palliat Care"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/1049909120938629","article-title":"Patients With Fibrotic Interstitial Lung Disease Receive Supportive and Palliative Care Just Prior to Death","volume":"38","author":"N Smallwood","year":"2021","journal-title":"Am J Hosp Palliat Care"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.chest.2022.03.009","article-title":"Pulmonary Fibrosis Foundation. Provider Perspectives on and Access to Palliative Care for Patients With Interstitial Lung Disease","volume":"162","author":"RA Gersten","year":"2022","journal-title":"Chest"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1136\/thoraxjnl-2020-215917","article-title":"Quality of dying and death in patients with interstitial lung disease compared with lung cancer: an observational study","volume":"76","author":"T Koyauchi","year":"2021","journal-title":"Thorax"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12904-016-0158-8","article-title":"End-of-life care of patients with idiopathic pulmonary fibrosis","volume":"15","author":"K Rajala","year":"2016","journal-title":"BMC Palliat Care"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1177\/0269216314564239","article-title":"Discrepancy between symptom scoring and self-reported palliative care needs in a survey of interstitial lung disease patients","volume":"29","author":"S Tsim","year":"2015","journal-title":"Palliat Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1136\/bmjspcare-2012-000263","article-title":"\u2018I wish I knew more \u2026\u2019 the end-of-life planning and information needs for end-stage fibrotic interstitial lung disease: views of patients, carers and health professionals","volume":"3","author":"S Bajwah","year":"2013","journal-title":"BMJ Support Palliat Care"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1177\/0825859720936012","article-title":"Attitude and Barriers in Palliative Care and Advance Care Planning in Nonmalignant Chronic Lung Disease: Results From a Danish National Survey","volume":"35","author":"AR S\u00f8rensen","year":"2020","journal-title":"J Palliat Care"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1159\/000490667","article-title":"Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views","volume":"96","author":"TM Maher","year":"2018","journal-title":"Respiration"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1001\/jamainternmed.2019.0027","article-title":"Clinician-Family Communication About Patients' Values and Preferences in Intensive Care Units","volume":"179","author":"LP Scheunemann","year":"2019","journal-title":"JAMA Intern Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"00065","DOI":"10.1183\/23120541.00065-2016","article-title":"What patients with pulmonary fibrosis and their partners think: a live, educative survey in the Netherlands and Germany","volume":"3","author":"MJ van Manen","year":"2017","journal-title":"ERJ Open Res"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00422-2021","article-title":"Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?","volume":"8","author":"MS Wijsenbeek","year":"2022","journal-title":"ERJ Open Res"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2018-000360","article-title":"Specialist palliative care, psychology, interstitial lung disease (ILD) multidisciplinary team meeting: a novel model to address palliative care needs","volume":"5","author":"SL Barratt","year":"2018","journal-title":"BMJ Open Respir Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1513\/AnnalsATS.202405-495OC","article-title":"Prognostic Awareness and Knowledge of Acute Exacerbation in Patients Dying with Interstitial Lung Disease: A Nationwide Survey","volume":"22","author":"T Koyauchi","year":"2025","journal-title":"Ann Am Thorac Soc"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S2213-2600(14)70226-7","article-title":"An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial","volume":"2","author":"IJ Higginson","year":"2014","journal-title":"Lancet Respir Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/1049909120924995","article-title":"Early Integrated Palliative Care Bundle Impacts Location of Death in Interstitial Lung Disease: A Pilot Retrospective Study","volume":"38","author":"N Archibald","year":"2021","journal-title":"Am J Hosp Palliat Care"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jpainsymman.2017.10.016","article-title":"Beyond Idiopathic Pulmonary Fibrosis Diagnosis: Multidisciplinary Care With an Early Integrated Palliative Approach Is Associated With a Decrease in Acute Care Utilization and Hospital Deaths","volume":"55","author":"M Kalluri","year":"2018","journal-title":"J Pain Symptom Manage"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1089\/jpm.2018.0400","article-title":"Assessing Patterns of Palliative Care Referral and Location of Death in Patients with Idiopathic Pulmonary Fibrosis: A Sixteen-Year Single-Center Retrospective Cohort Study","volume":"22","author":"RH Zou","year":"2019","journal-title":"J Palliat Med"},{"key":"ref42","article-title":"Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness","volume":"3","author":"H Barnes","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12931-020-01452-7","article-title":"Palliation of chronic breathlessness with morphine in patients with fibrotic interstitial lung disease \u2013 a randomised placebo-controlled trial","volume":"21","author":"S Kronborg-White","year":"2020","journal-title":"Respir Res"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00702-2023","article-title":"Regular, low-dose, sustained-release morphine for persisting breathlessness in interstitial lung disease: a randomised, double-blind, placebo-controlled, crossover trial","volume":"62","author":"DH Ferreira","year":"2023","journal-title":"Eur Respir J"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"725","DOI":"10.2169\/internalmedicine.55.536227041155","article-title":"Continuous Intravenous Morphine Infusion for Severe Dyspnea in Terminally Ill Interstitial Pneumonia Patients","volume":"55","author":"M Takeyasu","year":"2016","journal-title":"Intern Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01278-2018","article-title":"Safety of benzodiazepines and opioids in\u00a0interstitial lung disease: a national prospective study","volume":"52","author":"S Bajwah","year":"2018","journal-title":"Eur Respir J"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.chest.2018.06.038","article-title":"Treatment of Interstitial Lung Disease Associated Cough: CHEST Guideline and Expert Panel Report","volume":"154","author":"SS Birring","year":"2018","journal-title":"Chest"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S2213-2600(23)00432-0","article-title":"Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial","volume":"12","author":"Z Wu","year":"2024","journal-title":"Lancet Respir Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300083","article-title":"Nalbuphine Tablets for Cough in Patients with Idiopathic Pulmonary Fibrosis","volume":"2","author":"TM Maher","year":"2023","journal-title":"NEJM Evid"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0140-6736(21)02348-5","article-title":"Efficacy and safety of gefapixant, a P2X(3) receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials","volume":"399","author":"LP McGarvey","year":"2022","journal-title":"Lancet"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s41030-021-00162-9","article-title":"Treatment of persistent cough in subjects with idiopathic pulmonary fibrosis (IPF) with Gefapixant, a P2X3 antagonist, in a randomized placebo-controlled clinical trial","volume":"7","author":"FJ Martinez","year":"2021","journal-title":"Pulm Ther"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.21037\/jtd.2019.12.27","article-title":"Aerobic and breathing exercises improve dyspnea, exercise capacity and quality of life in idiopathic fibrosis patients: systematic review and meta-analysis","volume":"12","author":"M Hanada","year":"2020","journal-title":"J Thorac Dis"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/1479972311422547","article-title":"Improvement in health status following cough-suppression physiotherapy for patients with chronic cough","volume":"8","author":"AS Patel","year":"2011","journal-title":"Chron Respir Dis"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/jcm14010291","article-title":"Examining Cough\u02bcs Role and Relief Strategies in Interstitial Lung Disease","volume":"14","author":"CY Lim","year":"2025","journal-title":"J Clin Med"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/imj.14856","article-title":"Investigation burden for patients with fibrotic interstitial lung disease at the end of life","volume":"50","author":"H Guo","year":"2020","journal-title":"Intern Med J"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1089\/jpm.2016.0258","article-title":"Referral to Palliative Care Infrequent in Patients with Idiopathic Pulmonary Fibrosis Admitted to an Intensive Care Unit","volume":"20","author":"Z Liang","year":"2017","journal-title":"J Palliat Med"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1513\/AnnalsATS.201510-667OC","article-title":"Palliative Care for Patients Dying in the Intensive Care Unit with Chronic Lung Disease Compared with Metastatic Cancer","volume":"13","author":"CE Brown","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12931-022-02204-5","article-title":"End-of-life care for idiopathic pulmonary fibrosis patients with acute exacerbation","volume":"23","author":"N Akiyama","year":"2022","journal-title":"Respir Res"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/SPC.0000000000000068","article-title":"Noninvasive ventilation as a palliative measure","volume":"8","author":"AH Gifford","year":"2014","journal-title":"Curr Opin Support Palliat Care"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/s0761-8425(08)75088-5","article-title":"Place de la ventilation non-invasive dans les soins palliatifs et en fin de vie [Noninvasive ventilation in palliative care and near the end of life]","volume":"25","author":"C Perrin","year":"2008","journal-title":"Rev Mal Respir"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149649","article-title":"The Role of Noninvasive Ventilation in Patients with \u201cDo Not Intubate\u201d Order in the Emergency Setting","volume":"11","author":"M Vila\u00e7a","year":"2016","journal-title":"PLoS One"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104897","article-title":"Acute respiratory failure in critically ill patients with interstitial lung disease","volume":"9","author":"L Zafrani","year":"2014","journal-title":"PLoS One"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/crj.13223","article-title":"Mechanical ventilation for acute respiratory failure due to idiopathic pulmonary fibrosis versus connective tissue disease-associated interstitial lung disease: Effectiveness and risk factors for death","volume":"14","author":"Z Luo","year":"2020","journal-title":"Clin Respir J"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000030524","article-title":"Which factors are helpful for the early determination of treatment level in patients with interstitial lung disease in the intensive care unit to minimize the suffering in their end of life? A retrospective study","volume":"101","author":"SH Kim","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12931-022-02004-x","article-title":"Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study","volume":"23","author":"T Koyauchi","year":"2022","journal-title":"Respir Res"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"e411","DOI":"10.1136\/bmjspcare-2017-001489","article-title":"Advance care planning for the severely ill in the hospital: a randomized trial","volume":"12","author":"T Krones","year":"2019","journal-title":"BMJ Support Palliat Care"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1177\/10499091221083575","article-title":"Impact of Palliative Care in End-of-Life of Fibrotic Interstitial Lung Disease Patients","volume":"39","author":"GT Chai","year":"2022","journal-title":"Am J Hosp Palliat Care"}],"container-title":["Pneumologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2624-3671.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:51:52Z","timestamp":1757631112000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2624-3671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":66,"journal-issue":{"issue":"09","published-online":{"date-parts":[[2025,9,11]]},"published-print":{"date-parts":[[2025,9]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2624-3671","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0934-8387","1438-8790"],"issn-type":[{"value":"0934-8387","type":"print"},{"value":"1438-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]}}}